R&D credit choice

President Obama's proposal to permanently extend the R&D tax credit will require biotech companies to make some new choices if the Congress buys into the latest stimulus package from the White House

Currently, companies must choose between using a complex formula for calculating the R&D credit that provides a 20% credit rate, and a simpler formula that provides a 14% rate. Under Obama's plan, the simpler rate would be increased to 17%...